Vitalhub Corp. (TSX:VHI)
Canada · Delayed Price · Currency is CAD | Market Cap | 494.05M -32.2% |
| Revenue (ttm) | 127.08M +53.8% |
| Net Income | 7.48M +51.2% |
| EPS | 0.12 +48.7% |
| Shares Out | 63.34M |
| PE Ratio | 64.99 |
| Forward PE | 29.95 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 158,429 |
| Open | 7.68 |
| Previous Close | 7.71 |
| Day's Range | 7.58 - 7.84 |
| 52-Week Range | 6.46 - 11.17 |
| Beta | 0.89 |
| Analysts | Buy |
| Price Target | 12.39 (+58.85%) |
| Est. Earnings | Nov 5, 2026 |
About Vitalhub
Vitalhub Corp., together with its subsidiaries, provides technology and software solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. The company offers patient flow, operational visibility, and patient journey optimization solutions for hospital and integrated health environments, including SHREWD, Intouch with Health, Strata Health, MedCurrent, Beautiful Information, My Pathway, BookWise Solutions, Jayex Acute, MCAP, and Oculys. It also provides electr... [Read more]
Financial Performance
In 2025, Vitalhub's revenue was 108.97 million, an increase of 58.86% compared to the previous year's 68.59 million. Earnings were 6.11 million, an increase of 103.76%.
Financial StatementsAnalyst Summary
According to 11 analysts, the average rating for VHI stock is "Buy." The 12-month stock price target is $12.39, which is an increase of 58.85% from the latest price.
News
VitalHub Announces Expansion of AI Capabilities with Launch of AI Scribe
VitalHub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) announced today the launch of VitalHub AI Scribe, an ambient clinical intelligence (“ACI”) solution that captures conversations, id...
VitalHub Announces Expansion of AI Capabilities with Launch of AI Scribe
TORONTO, Sept. 15, 2026 (GLOBE NEWSWIRE) -- VitalHub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) announced today the launch of VitalHub AI Scribe, an ambient clinical intelligence (“AC...
Vitalhub Q2 Earnings Call Highlights
Vitalhub TSE: VHI reported second-quarter 2026 revenue of CAD 31.7 million, up 33% from the prior-year period, while annual recurring revenue surpassed CAD 100 million for the first time.
Vitalhub Earnings Call Transcript: Q2 2026
Q2 2026 saw ARR surpass CAD 100 million with 10% organic growth and total revenue up 33% year-over-year. Adjusted EBITDA margin reached 26%, cash reserves remain strong, and the Buddy Healthcare acquisition enhances digital offerings. Ongoing M&A and AI investments support future growth.
Vitalhub MD&A: Q2 2026
Vitalhub filed a regulatory document on August 7, 2026 disclosing important business information.
Vitalhub Report: Q2 2026
Vitalhub published a report on August 7, 2026 containing material business information for investors and shareholders.
Vitalhub Earnings release: Q2 2026
Vitalhub released its Q2 2026 earnings on August 7, 2026, summarizing the period's financial results.
VitalHub Announces Normal Course Issuer Bid
TORONTO, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (“VitalHub” or the “Company”) announced today that the Toronto Stock Exchange (the "Exchange") has accepted a notice f...
VitalHub Reports Second Quarter 2026 Results
Annual Recurring Revenue (“ARR”)⁽¹⁾ up 28% YoY to $101.5 million Total Revenue up 33% YoY to $31.7 million Adjusted EBITDA⁽¹⁾ up 29% YoY to $8.2 million
VitalHub Announces Q2 2026 Conference Call Date
TORONTO, Ontario, July 29, 2026 (GLOBE NEWSWIRE) -- VitalHub Corp. (TSX:VHI) (OTCQX:VHIBF) (the "Company" or "VitalHub") announced today that it will release financial results for the second quarter 2...
VitalHub Announces Acquisition of Buddy Healthcare
TORONTO, July 13, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (“VitalHub” or the “Company”) announced today that it has acquired Buddy Healthcare Ltd Oy (“Buddy Healthcare”), a car...
VitalHub Announces Results of Annual General Meeting of Shareholders
TORONTO, June 26, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) announced today the voting results from its annual general meeting of shareholders held ...
VitalHub Announces Deployments of Referral Management Solutions
TORONTO, June 16, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) announced today that Novari Health, a VitalHub company, has executed agreements to imple...
Vitalhub Earnings Call Transcript: Q1 2026
Reported 47% year-over-year revenue growth and 11% organic ARR growth, with improved margins and strong cash position. Novari led growth, AI initiatives advanced, and board changes were made. Confident in double-digit ARR growth for 2026.
Vitalhub Earnings release: Q1 2026
Vitalhub released its Q1 2026 earnings on May 8, 2026, summarizing the period's financial results.
Vitalhub Report: Q1 2026
Vitalhub published a report on May 8, 2026 containing material business information for investors and shareholders.
Vitalhub MD&A: Q1 2026
Vitalhub filed a regulatory document on May 8, 2026 disclosing important business information.
VitalHub Reports First Quarter 2026 Results
Annual Recurring Revenue (“ARR”)⁽¹⁾ up 34% YoY to $99.1 million Total Revenue up 47% YoY to $31.9 million Adjusted EBITDA⁽¹⁾ up 42% YoY to $8.0 million TORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- Vitalh...
VitalHub Announces Planned Board Succession with Appointment of Allan Brett as Chairman
TORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) announced today proposed changes to its Board of Directors (the “Board”) in connection wi...
VitalHub Announces Q1 2026 Conference Call Date
TORONTO, April 29, 2026 (GLOBE NEWSWIRE) -- VitalHub Corp. (TSX:VHI) (OTCQX:VHIBF) (the "Company" or "VitalHub") announced today that it will release financial results for the first quarter 2026 ended...
Vitalhub price target lowered to C$11 from C$13.50 at Stifel
Stifel lowered the firm’s price target on Vitalhub (VHIBF) to C$11 from C$13.50 and keeps a Buy rating on the shares.
Vitalhub price target lowered to C$11 from C$12 at RBC Capital
RBC Capital lowered the firm’s price target on Vitalhub (VHIBF) to C$11 from C$12 and keeps an Outperform rating on the shares.
Vitalhub Earnings Call Transcript: Q4 2025
Full-year revenue surpassed CAD 100 million with 10% ARR growth and strong Q4 results. Integration of recent acquisitions is driving cost synergies and cross-selling, while AI initiatives are expected to contribute to revenue from mid-2026. Cash position remains robust, supporting further M&A.
Vitalhub Earnings release: Q4 2025
Vitalhub released its Q4 2025 earnings on March 19, 2026, summarizing the period's financial results.
Vitalhub MD&A: Q4 2025
Vitalhub filed a regulatory document on March 19, 2026 disclosing important business information.